MedTrace Logo

Continuum™ Metal Bearing System in Total Hip Arthroplasty

NCT03382652 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2025-01-03

Study results available
· View outcomes & findings →

Summary

The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and outcome data on the Continuum Metal Bearing System in primary total hip arthroplasty.

Conditions

  • Avascular Necrosis
  • Osteoarthritis
  • Inflammatory Arthritis
  • Post-traumatic; Arthrosis
  • Total Hip Arthroplasty

Interventions

DEVICE

Metal-on-Metal Articulation

\<Metal-on-Metal Articulation\>: Metasul® Taper Liner and Metasul Femoral Head, \<Acetabular Component\>:Continuum Acetabular Shell, \<Femoral Component\>: Zimmer® M/L Taper Hip Stem

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Hassan Achakri · Zimmer Biomet

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-09
Primary Completion
2022-10-22
Completion
2022-10-22
FDA Device
Yes

Countries

  • United States
  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03382652 on ClinicalTrials.gov